CAMILLE HOOPES: Open Payments
NPI 1457036535 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 63 payments from 19 companies in 2025. Trend: 2023 $714 · 2024 $905 · 2025 $1,341
Food & beverage: $1,298Education: $43
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 11 | $191 |
| Medtronic, Inc. | 8 | $161 |
| Lilly USA, LLC | 7 | $147 |
| SANOFI-AVENTIS U.S. LLC | 4 | $113 |
| Dexcom, Inc. | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Mannkind Corporation | 3 | $82 |
| Insulet Corporation | 4 | $73 |
| Amneal Pharmaceuticals LLC | 4 | $70 |
| Ascendis Pharma Endocrinology Inc | 2 | $54 |
Products named: iLet Bionic Pancreas, MINIMED 780G, TZIELD, JARDIANCE, Dexcom G6 Transmitter, LEQVIO, AFREZZA, Omnipod.
Industry payments across AZ — which companies pay providers there.
